Leaflet LYNAGEX 82.5mg prolonged-release tablets

Product code:
W71036001
Quantity:
30
Indicated for:
epilepsy; neuropathic pain; anxiety
Route of administration:
oral
Substance:
pregabalin (antiepileptic)
ATC
N02BF02 — Nervous system | Other analgesics and antipyretics | Gabapentinoids

Precautions:

Driving impairment

This medicine may affect your ability to drive or use machines.

Dose adjustment in hepatic impairment

Dose adjustment may be needed in liver disease.

Dose adjustment in renal impairment

Dose adjustment may be needed in kidney disease.

Dizziness / vertigo

This medicine may cause dizziness or vertigo.

Breastfeeding warning

Use during breastfeeding only on medical advice.

Pregnancy warning

Use during pregnancy only on medical advice.

Suicidal ideation / mental changes

Seek medical help if suicidal thoughts or major behavior changes occur.

Withdrawal / do not stop abruptly

Do not stop treatment abruptly without medical advice.

Drowsiness / sedation

This medicine may cause drowsiness or reduced alertness.

Pregabalin is a medication used to treat neuropathic pain, epilepsy, and generalized anxiety disorder. It belongs to the class of drugs known as antiepileptics or anticonvulsants and works by reducing excessive nerve activity in the central nervous system, helping to relieve pain and other symptoms.

It is indicated for the treatment of neuropathic pain associated with conditions such as diabetic neuropathy, postherpetic neuralgia, or nerve injuries. It is also used as an adjunct therapy in epilepsy to reduce the frequency of partial seizures and in the treatment of generalized anxiety disorder, alleviating symptoms such as tension, irritability, and insomnia.

Common side effects include dizziness, drowsiness, weight gain, dry mouth, and difficulty concentrating. It is important to take pregabalin as prescribed by a healthcare provider, and discontinuation of the treatment should be done gradually to avoid withdrawal symptoms.

General data about LYNAGEX 82.5mg

Substance:
pregabalin
Date of latest medicines list:
01-05-2025
Product code:
W71036001
Concentration:
82.5mg
Pharmaceutical form:
prolonged-release tablets
Quantity:
30
Product type:
Generic medicine
Prescription status:
P-RF — Medicines dispensed with a medical prescription that is retained by the pharmacy and cannot be renewed.

Marketing authorisation

Manufacturer:
KEVARO GROUP LTD - BULGARIA
Holder:
EXELTIS POLAND SP. Z O. O. - POLONIA
Number:
15373/2024/01
Shelf life:
3 years

Pharmaceutical forms available for pregabalin

Concentrations available for pregabalin

  • 100mg
  • 125mg
  • 150mg
  • 165mg
  • 175mg
  • 200mg
  • 20mg/ml
  • 225mg
  • 250mg
  • 25mg
  • 275m
  • 300mg
  • 330mg
  • 50mg
  • 75mg
  • 82.5mg